CYP19A1 and Alzheimer disease: The dramatic decline in ovarian estrogen and progesterone after menopause in women, while estrogen in the male brain can be produced by aromatase-catalyzed testosterone or de novo synthesis in neurons or glial cells is thought to account for the increased susceptibility to AD in women (Kong et al., 2019).